|
|
| Time/Date | Code | Headline | Source | Impact |
|---|---|---|---|---|
| 13:30 23-Oct-2012 | MEDG | EPODURE to be presented at Kidney Week 2012 | RNS | -3.92%  |
| 15:35 17-Oct-2012 | MEDG | Filing of Shelf Registration | RNS | -6.88% |
| 18:01 14-Sep-2012 | MEDG | Directors Dealings | RNS | -1.92% |
| 10:01 05-Sep-2012 | MEDG | Director's Dealings | RNS | -3.63% |
| 18:00 29-Aug-2012 | MEDG | Initiates First Two Hep C Trials With INFRADURE | RNS | +9.89%  |
| 15:00 28-Aug-2012 | MEDG | Medgenics Mourns the Loss of Board Member | RNS | +15.24% |
| 09:55 28-Aug-2012 | MEDG | Directors Dealings | RNS | +15.24% |
| 08:23 22-Aug-2012 | MEDG | Exercise of Options | RNS | +6.84% |
| 15:00 14-Aug-2012 | MEDG | Dr. Marvin Garovoy appointed Chief Medical Officer | RNS | -7.22% |
| 15:00 13-Aug-2012 | MEDG | Second Quarter 2012 Financial Results | RNS | -6.56% |
| 13:30 23-Jul-2012 | MEDG | Registration of Shares | RNS | -15.74% |
| 16:00 19-Jul-2012 | MEDG | Admission of Shares to AIM | RNS | -11.63% |
| 15:43 17-Jul-2012 | MEDG | Launch of Phase IIa clinical trial of EPODURET | RNS | -1.37% |
| 14:50 17-Jul-2012 | MEDG | Block Listing interim review | RNS | -1.37% |
| 07:00 09-Jul-2012 | MEDG | Admission of Shares | RNS | +15.47% |
| 14:15 02-Jul-2012 | MEDG | Further re. Board Appointment | RNS | +19.56% |
| 14:15 02-Jul-2012 | MEDG | Medgenics Appoints Dr. Sol Barer as Chairman | RNS | +19.56% |
| 14:35 28-Jun-2012 | MEDG | Exercise of Options | RNS | +7.66% |
| 16:00 20-Jun-2012 | MEDG | Receives Orphan Drug Designation from FDA | RNS | +47.23% |
| 14:25 19-Jun-2012 | MEDG | Medgenics, Inc. Raises $9.5 million | RNS | +36.80% |
MEDGENICS(REGS) - News Analysis
Company overview
Group site
Investor relations
Press office
Careers
Events & Studios
Academy Training
Business days
Regulatory policy
© 2013 London Stock Exchange plc. All rights reserved